- Home
- NFG vs LEGN Comparison
NFG vs LEGN Comparison
Compare NFG & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFG
- LEGN
- Stock Information
- Founded
- NFG 1902
- LEGN 2014
- Country
- NFG United States
- LEGN United States
- Employees
- NFG N/A
- LEGN N/A
- Industry
- NFG Oil/Gas Transmission
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- NFG Utilities
- LEGN Health Care
- Exchange
- NFG Nasdaq
- LEGN Nasdaq
- Market Cap
- NFG 7.0B
- LEGN 7.0B
- IPO Year
- NFG N/A
- LEGN 2020
- Fundamental
- Price
- NFG $80.52
- LEGN $29.05
- Analyst Decision
- NFG Buy
- LEGN Strong Buy
- Analyst Count
- NFG 2
- LEGN 13
- Target Price
- NFG $81.00
- LEGN $75.67
- AVG Volume (30 Days)
- NFG 614.2K
- LEGN 1.6M
- Earning Date
- NFG 04-30-2025
- LEGN 05-13-2025
- Dividend Yield
- NFG 2.55%
- LEGN N/A
- EPS Growth
- NFG N/A
- LEGN N/A
- EPS
- NFG 0.43
- LEGN N/A
- Revenue
- NFG $2,068,941,000.00
- LEGN $728,303,000.00
- Revenue This Year
- NFG $29.58
- LEGN $64.21
- Revenue Next Year
- NFG $10.60
- LEGN $53.69
- P/E Ratio
- NFG $189.78
- LEGN N/A
- Revenue Growth
- NFG 5.94
- LEGN 112.46
- 52 Week Low
- NFG $53.03
- LEGN $27.34
- 52 Week High
- NFG $83.35
- LEGN $60.87
- Technical
- Relative Strength Index (RSI)
- NFG 53.58
- LEGN 40.43
- Support Level
- NFG $80.42
- LEGN $28.14
- Resistance Level
- NFG $81.88
- LEGN $31.12
- Average True Range (ATR)
- NFG 1.35
- LEGN 1.87
- MACD
- NFG -0.14
- LEGN -0.22
- Stochastic Oscillator
- NFG 44.73
- LEGN 27.32
About NFG National Fuel Gas Company
National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.